Bolt Biotherapeutics announced it will participate in the Stifel 2026 Healthcare Conference and the Jefferies Global Healthcare Conference in London. This follows its recent acquisition of Prana Therapies, which included a $120 million private placement financing. Bolt is focusing on advancing Prana’s pipeline, especially the PRA-216 antibody in Phase 2 trials for inflammatory diseases. The company will host investor meetings and provide a live webcast of its Stifel presentation.
Bolt Biotherapeutics news offers context for readers following healthcare stocks. For readers following healthcare stocks, here is Pluang's market snapshot as of Nov 03, 2026 20:11 WIB: Out of 150 priced US health-sector stocks, 75 rose and 69 fell. Notable movers include TVTX at USD 46.23 down 6.15%, INO at USD 1.77 down 6.08% with 51% sell order activity, and PHG at USD 29.00 up 5.11%.
The global Automatic FOUP Opener Market is projected to grow from USD 4.41 billion in 2026 to USD 6.04 billion by 2032, expanding at a CAGR of 5.36%. Growth is driven by increasing fab automation, stricter contamination control requirements, and dema...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
